.png)
Optimizing an assembly process for the development of a new drug
Overcoming industrialization barriers through the mechanisms of living organisms

Context
Bionnov intervened with a company developing a disruptive medical solution, which was facing strong industrialization constraints during the assembly of its product.
The mission was to identify, through biomimicry, possible solutions to two specific problems: eliminating the formation of aggregates at the outlet of the distribution nozzle and eliminating any contact between the medical substance and the walls of the device.
Goals
Targeting biological models of interest that address the two technological challenges
Provide complete documentation on each of the selected models.
To propose preliminary concepts for biomimetic transposition applicable to the industrial context
Key topics explored
Elimination of aggregate formation at the outlet of a distribution nozzle
Elimination of contact between medical substance and surfaces (anti-adhesion)
Self-cleaning and super-hydrophobicity in living organisms
Customer
Pharmaceutical industry player — Confidential client

Achievements
On-site intervention: visit to the client's production line
Information gathering workshop: review of technical specifications, documentation of pre-existing solutions and their strengths and weaknesses
Analysis of technical solution levers using a biomimetic approach
Targeted biological monitoring focusing on: self-cleaning and super-hydrophobicity, anti-adhesion
Identification of 6 species of interest, 3 of which are highly relevant to the client's specific industrial context
Deliverables
Biological documentation of the 6 species of interest with a detailed bibliography
Proposal of 3 pre-concepts of biomimetic transposition

_edited.png)








